Argeris N. Karabelas, Director at Vanda Pharmaceuticals Inc. (VNDA), sold 200,000 shares at $11.57 ($2.3M) on 2009-12-07, disclosed to the SEC on 2009-12-08.
Open-market sale of $2.3M VNDA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.70 | 100,000 | $1.2M | 50.3% |
| 2 | $11.57 | 100,000 | $1.2M | 49.7% |
| Total | $11.63 avg | 200,000 | $2.3M | 100% |
| Filing → |
| RGNX | SELL | 2024-08-05 | $136K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |